VIRX - Bollinger Breakout with Volume

Viracta (VIRX) is a clinical stage biotech firm focused on the treatment of Epstein-Barr related cancers which is one of the most common virus infections found in humans. Had a good run last week, and one of those stocks that can really move with some good news. Might be worth a look.

Comment:

Stock popped 10% the next day before getting stopped out on a big drop. I traded in an out a couple of times as it was recovering but kept getting stopped out on all the volatility. Would have been a nice 80% run for anyone who did capture the move off the bottom. Big green volume candle on the most recent day so keeping an eye on it again.